Enhanced recovery after surgery in radical resection of primary liver cancer

Objective To investigate the clinical value of enhanced recovery after surgery (ERAS) in radical resection of primary liver cancer. Methods In this study 68 patients were randomly assigned into the ERAS group (n=35), and control group (n=33). Results Comparing with control group, there was significant differences in ERAS group with less volume of intraoperative intravenous fluid (t=2.812, P 0.05). Conclusion ERAS was safe and effective for patients undergoing radical resection of primary liver cancer. Key words: Carcinoma, hepatocellular; Hospital convalescent; Hepatectomy